News from united therapeutics corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 05, 2019, 06:00 ET United Therapeutics Corporation to Present at Goldman Sachs 40th Annual Global Healthcare Conference

United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics,...


May 28, 2019, 06:00 ET United Therapeutics Corporation To Present at Jefferies 2019 Healthcare Conference

United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics,...


May 01, 2019, 06:00 ET United Therapeutics Corporation Reports First Quarter 2019 Financial Results

United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended March 31, 2019. "I'm very pleased to...


Apr 29, 2019, 06:00 ET United Therapeutics Announces FDA Approval Of XPS™ And Steen Solution™ Used To Perform Centralized Ex-Vivo Lung Perfusion Services

United Therapeutics Corporation (Nasdaq: UTHR) today announced that its collaborator, XVIVO Perfusion, Inc., a subsidiary of XVIVO Perfusion AB (STO: ...


Apr 24, 2019, 06:00 ET United Therapeutics Corporation To Report First Quarter 2019 Financial Results Before The Market Opens On Wednesday, May 1, 2019

United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its first quarter 2019 financial results before the market opens...


Apr 17, 2019, 22:52 ET United Therapeutics Issues Statement In Response To Meritless Lawsuit

United Therapeutics Corporation (Nasdaq: UTHR) was named as a defendant, along with Smiths Medical ASD, Inc., in a lawsuit filed in federal court by...


Apr 08, 2019, 06:00 ET United Therapeutics Announces BEAT Study of Esuberaprost Does Not Meet Primary Endpoint

United Therapeutics Corporation (Nasdaq: UTHR) today announced that the BEAT clinical study of esuberaprost tablets in patients suffering from...


Mar 12, 2019, 06:00 ET United Therapeutics Corporation to Present at Oppenheimer 29th Annual Healthcare Conference

United Therapeutics Corporation (Nasdaq: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United...


Mar 04, 2019, 06:00 ET United Therapeutics Corporation To Present At Cowen And Company 39th Annual Health Care Conference

United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics,...


Feb 27, 2019, 06:00 ET United Therapeutics Corporation Reports 2018 Fourth Quarter And Annual Financial Results

United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the fourth quarter and year ended December 31, 2018. "2018...


Feb 20, 2019, 06:00 ET United Therapeutics Corporation To Report Fourth Quarter And Annual 2018 Financial Results Before The Market Opens On Wednesday, February 27, 2019

United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its fourth quarter and annual 2018 financial results before the...


Jan 31, 2019, 20:00 ET Survival Data From FREEDOM-EV Study of Orenitram Presented at the Pulmonary Vascular Research Institute Annual World Congress

United Therapeutics Corporation (Nasdaq: UTHR) today announced that key data from the FREEDOM-EV study of Orenitram® (treprostinil) extended-release...


Jan 24, 2019, 20:00 ET United Therapeutics Announces Closing Of License Agreement With Arena Pharmaceuticals For Ralinepag

United Therapeutics Corporation (Nasdaq: UTHR) today announced the closing of the transactions contemplated by its license agreement with Arena...


Dec 31, 2018, 06:00 ET United Therapeutics Corporation To Present At 37th Annual J.P. Morgan Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United...


Nov 29, 2018, 16:30 ET Health Canada Approves Unituxin® For The Treatment Of Pediatric High-Risk Neuroblastoma

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Health Canada has approved PrUnituxin (dinutuximab for injection), in combination ...


Nov 01, 2018, 06:00 ET Nilda Mesa Joins The United Therapeutics Corporation Board Of Directors

United Therapeutics Corporation (NASDAQ: UTHR) announced today the appointment of Nilda Mesa to its Board of Directors as an independent director....


Oct 31, 2018, 06:00 ET United Therapeutics Corporation Reports Third Quarter 2018 Financial Results

United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the quarter ended September 30, 2018. "We are pleased to see ...


Oct 24, 2018, 06:00 ET United Therapeutics Corporation To Report Third Quarter 2018 Financial Results Before The Market Opens On Wednesday, October 31, 2018

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its third quarter 2018 financial results before the market opens...


Oct 16, 2018, 06:00 ET United Therapeutics And MannKind Announce Closing Of License And Collaboration Agreement

United Therapeutics Corporation (Nasdaq: UTHR) and MannKind Corporation (Nasdaq: MNKD) today announced the closing of their pending worldwide...


Sep 18, 2018, 06:00 ET United Therapeutics Corporation To Host Science Day 2018

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will host Science Day 2018 in New York City on Monday, September 24th,...


Sep 04, 2018, 06:00 ET United Therapeutics And MannKind Announce Collaboration For Pulmonary Hypertension Products

United Therapeutics Corporation (Nasdaq: UTHR) and MannKind Corporation (Nasdaq: MNKD) today announced that they have entered into a worldwide...


Aug 30, 2018, 07:08 ET United Therapeutics Corporation Completes Acquisition Of SteadyMed Ltd.

United Therapeutics Corporation (NASDAQ: UTHR) ("United Therapeutics") today announced that it has closed the merger of SteadyMed Ltd. (NASDAQ: STDY) ...


Aug 08, 2018, 20:00 ET United Therapeutics Announces Settlement Of Patent Litigation With Watson Laboratories, Inc. Relating To Tyvaso

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into a Settlement Agreement with Watson Laboratories, Inc....


Aug 08, 2018, 06:00 ET United Therapeutics Announces FREEDOM-EV Study Of Orenitram Meets Primary Endpoint

United Therapeutics Corporation (NASDAQ: UTHR) today announced that preliminary analysis indicates that the FREEDOM-EV clinical study of Orenitram®...


Aug 07, 2018, 16:00 ET United Therapeutics Corporation To Present At 2018 Wedbush PacGrow Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics,...